Etanercept (biological response modifier) modulates clinical, morphological and immunoistochemical profile of psoriatic disease, acting on VEGF, CTACK, and factor VIII cutaneous expression: open label clinical trial / Campanati, Anna; Goteri, Gaia; Sabato, S.; Offidani, Annamaria. - 2010:(2010), pp. 193-212.
Etanercept (biological response modifier) modulates clinical, morphological and immunoistochemical profile of psoriatic disease, acting on VEGF, CTACK, and factor VIII cutaneous expression: open label clinical trial
CAMPANATI, Anna;GOTERI, Gaia;OFFIDANI, ANNAMARIA
2010-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.